Dr. Anthony Mancuso, Professor and Chairman, Department of Radiology, University of Florida College of Medicine

This affiliation provides an opportunity to educate radiology residents on developments in using AI in medical imaging and its focus on advancement in the delivery of health care.”

— Dr. Anthony Mancuso

SAN DIEGO, CA, USA, July 31, 2018 / — CureMetrix®, a company developing investigational, physics-based artificial intelligence and deep-learning software to help radiologists achieve more accurate readings of breast images, signed an agreement with the University of Florida to collect five years of anonymized images and clinical data to continue developing best-in-class computer-aided detection (CAD) tools for mammographers. As part of the agreement, the University of Florida will be using the CureMetrix software in an educational and investigational setting to continue evaluating its impact.

“The key to developing the most effective artificial intelligence (AI) software lies in our ability to curate high-quality data to properly train and validate the algorithm. We are thrilled to have a collaboration with the university’s academic health center, which is at the forefront of clinical care to help us usher in the next era of AI products in medical imaging. Our goal continues to be to develop a CAD that works to improve outcomes for patients and hospitals,” stated Kevin Harris, Chief Executive Officer of CureMetrix.

The University of Florida is one of the nation’s top research universities and currently offers state-of-the-art technology in breast imaging.

“This affiliation provides an opportunity to educate radiology residents on developments in using AI in medical imaging and its focus on advancement in the delivery of health care. It is an exciting collaboration and has the potential to help us continue to maintain the highest standard of care possible as we aim to improve clinical efficiency and patient outcomes,” said Anthony Mancuso, M.D., a professor and chair of the Department of Radiology in the UF College of Medicine.

CureMetrix currently has two investigational products for digital mammography, cmAssist®, a physics-based CAD software that identifies and quantifies regions of interest and cmTriage™, a worklist sorting and optimization tool for the prioritization of studies based on suspicious regions of interest. The company is currently conducting clinical trials to submit both solutions to the FDA in upcoming months.

With data from the University of Florida, CureMetrix will continue developing a CAD software for 3D tomosynthesis.

For more information about how to collaborate with CureMetrix as a data partner or a clinical study site, please contact or visit

About CureMetrix
CureMetrix® was founded in 2014 on the belief that better medical image analysis technology could lead to better outcomes for breast cancer patients. The company is developing investigational, physics-based artificial intelligence and deep learning solutions to help radiologists achieve more accurate readings of breast images. Through its research partnerships with leading hospital radiology departments, CureMetrix has evaluated more than 500,000 mammogram images to identify potential false negatives, which are undiagnosed cancers, and false positives, which are unnecessary recalls of patients to review anomalies that turn out to be normal. False negatives can occur at a rate of about one in five breast cancers.1 False positives affect 7-12 percent of all women after an initial mammogram.2 Reducing false positives could save a significant portion of the $4 billion per year spent on unneeded and sometimes invasive procedures such as biopsies.3 More importantly, reducing false negatives could save lives as well as reduce the cost and difficulty of cancer treatment through early detection.

Our goal is to create CAD that Works®. Improving computer-aided detection through a robust physics-based algorithm for detecting cancer empowers radiologists, supports their patients and reduces costs while improving clinical outcomes. To learn more about CureMetrix, visit


Elise Crispen
email us here

Source: EIN Presswire

Prostate Cancer Foundation of Chicago to Host Free Prostate Cancer Screening

On Friday, September 7, 2018, Prostate Cancer Foundation of Chicago will be hosting a free prostate cancer screening.

WESTMONT, IL, UNITED STATES, July 30, 2018 / — On Friday, September 7, 2018, Prostate Cancer Foundation of Chicago will be hosting a free prostate cancer screening. The prostate screening includes a PSA blood test and a digital rectal exam (DRE). The event will take place as part of National Prostate Cancer Awareness Month.

The screening event will take place from 7 a.m. until 2 p.m at 815 Pasquinelli Drive, Westmont, Illinois. The DRE will be performed by a licensed physician and PSA results will be received within minutes of the test.

As a part of the free prostate cancer screening weekend, the Prostate Cancer Foundation of Chicago will also be hosting the 8th annual Run and Walk for Prostate Cancer Awareness. This charity event will take place on Sunday, September 9, 2018. The race starts at 8 a.m. and consists of a 5K run and 3K walk beginning and ending at Chicago Prostate Cancer Center.

The special host for this event is Dick Johnson, the NBC5 news anchor. Music will be played from a local cover band called, “Blue Sky Blind Band”. All registered participants in the 5K are timed, and the three fastest runners for each age group are recognized with a medal or a ribbon. First place winners in each age group also win a prize. There will also be numerous raffles, auctions, face painting, and more.

For more information regarding Prostate Cancer Foundation of Chicago’s free screening, visit , call 630.654.2515 or email For more information regarding the Run & Walk visit:

Prostate Cancer Foundation of Chicago is a non-profit organization dedicated to improving quality of care and quality of life by funding patient support programs, clinical research as well as professional and public education.

Chicago Prostate Cancer Center
Prostate Cancer Foundation of Chicago has the unique opportunity to help advance clinical research, prostate cancer education and screening by working hand-in-hand with Chicago Prostate Cancer Center, the only freestanding, full-service medical facility in the world solely dedicated to minimally invasive prostate cancer treatment options with a focus on quality of life.

Michelle Braccioforte
Prostate Cancer Foundation of Chicago
email us here

Source: EIN Presswire

A ‘SEA’lebration! The SEA Lab Marks the End of the 20 Year Celebration with A Special Event.

A Corpsmember shows young students the touch tanks.

Beloved local aquarium hosts a commemorative family-friendly celebration on Sunday, August 12 from 10:00AM-4:00PM.

LOS ANGELES, CA, USA, July 30, 2018 / —
Redondo Beach, California——July 2018 —— The SEA Lab, a program of the LA Conservation Corps will culminate the end of the 20 year ‘SEA’lebration on Sunday, August 12. There will be carnival games, touch tanks, kayaking adventures and tasty treats beginning at 10:00AM and running through 4:00PM. With a unique relationship with local power plants as well as the government organization, the Department of Fish and Wildlife, the organization has rescued and rehabilitated thousands of marine animals and used them to educate local students from various schools in the area.

Based on the border of Hermosa and Redondo Beach and located at 1021 N Harbor Drive in Redondo Beach, CA 90277 , the beloved local attraction has rescued thousands of marine animals in a wide array of species including: sea horses, moon jellies, octopus, halibut, sharks, sea bass and many more.

The SEA Lab Director, Maria Madrigal was one of the first people hired at the aquarium and has served in numerous roles before her most recent appointment states: “It’s been wonderful to observe the transformation from a rustic, bare-bones structure to the facility it is today. I’ve observed children I taught in grade school and watched them grow into our high school volunteers and some have become corpsmembers. I’ve witnessed injured marine life get rescued and recover to thriving animals.”

Occupying and rehabbing a once faded building has been a 20-year transformation with SEA Lab picking up multiple beautification awards. The once barely-noticed aquarium now greets nearly 20,000 students and families each year and has become a local tourist attraction for beach-goers and tourists.

About the LA Conservation Corps
The LA Conservation Corps is an environmentally-focused youth development organization. We transform the lives of youth from disadvantaged communities through work and education. Work projects improve the quality of life for our communities and protect the environment for future generations.


For more information, contact: Mike Mena at: 310-316-0612 or
# # #

Mike Mena
Los Angeles Conservation Corps
email us here

Source: EIN Presswire

Kathleen Johnson of UniverSoul Heart Returns to CUTV News Radio in a Two-Part Radio Series

BLOOMSBURG, PENNSYLVANIA, UNITED STATES, July 30, 2018 / — Traditional medicine has created a paradigm in which patients are only a passive participant in their health. We put so much trust in our doctors and physicians and their expertise and specialties, it's easy to detach ourselves.

Everything in the universe is energy. Everything we encounter is energy in some form. We're surrounded by it. We're made of it. When you take care of your energy, that's the path to wellness.

Kathleen Johnson is the founder of UniverSoul Heart, a holistic wellness practice specializing in complementary healing and spiritual growth. Kathleen is a facilitator, practitioner, and teacher of an energy medicine modality known as Reiki, a natural healing method that uses universal life energy to enhance the body's natural healing abilities.

“Reiki invites you to be an active participant in your health,” says Kathleen. “We can't just isolate the physical and assume that we're going to be well. We have to treat ourselves as holistic beings, which is what we are. “

Kathleen says it has always been her dream to create a thriving practice around something that fuels her passion.

“I have always been involved in some way in the helping profession. What I'm doing creates ripples that make a difference. This really just feeds my soul. I get excited thinking about the possibilities of how many people can be reached. Once you start to shift into that perspective that we are so much more than our physical selves, things begin to open up. Sometimes that shift in perspective can make all the difference.”

Kathleen says Reiki is the gateway for many fledgling energy healers because it is so fundamental and easy to learn. And it's available to everyone.

“I don't consider myself a healer: I work with healing energy; the energy is doing the healing, not me,” says Kathleen. “You don't need special talents or gifts or abilities to do it. It's really a gift from Spirit for all of us. And it can help us in so many ways, healing on all levels: physical, emotional, mental, and spiritual. There's no downside to Reiki.”

“Even though I use other modalities, I always come back to Reiki. I'm a certified past-life regression therapist, I do crystal work, I offer spiritual guidance. But the cornerstone of everything I do is Reiki. I incorporate Reiki into every other modality. When all else fails, Reiki is there. It is a beacon of guiding light-always.”

Even medical science is slowly coming around to the mind-body-spirit connection and incorporating energy medicine like Reiki into their healthcare model to enhance the physical healing process.

CUTV News Radio will feature Kathleen Johnson in an interview with Jim Masters on August 1st and August 8th at 11am EDT.

Listen to the show on BlogTalkRadio. If you have a question for our guest, call (347) 996-3389.

For more information on UniverSoul Heart, visit

Lou Ceparano
(631) 850-3314
email us here

Source: EIN Presswire

Famous Nutritionist, Pharmacist and Author Partners with RX Canna Care for New Product Line

Rx Canna Care

CBD Rx Canna Care

Dr. Earl Mindell‘s latest book ‘Healing With Hemp CBD Oil’ has been the catalyst for a
partnership with Rx Canna Care.

LOS ANGELES, CALIFORNIA, USA, July 27, 2018 / — Dr. Earl Mindell ‘s latest book ‘Healing With Hemp CBD Oil’ has been the catalyst for a partnership project. RX Canna Care, LLC will be creating a new product line for Savvy Wellness, LLC.

Dr. Earl Mindell, the famous author of over 62 books on nutrition, health, and anti-aging has recently published ‘ Healing With Hemp CBD Oil: A Simple Guide To Using the Powerful and Proven Health Benefits of CBD’.

Dr. Mindell is a pioneer in the natural health and wellness industry. His prolific contribution of natural guides to health has helped thousands of people seeking natural health alternatives. His famous international best seller ‘The Vitamin Bible’ has sold over 11 million copies in 35 languages.

‘Healing With Hemp CBD Oil’ gets rave reviews for the easy to read, clearly researched information on CBD. Dr. Mindell has always been ahead of the curve and it looks like the popularity of his latest book is hitting a nerve for CBD information seekers.

In addition to his invaluable information creations, Dr. Mindell has recently become involved in the development of a CBD product line for Savvy Wellness LLC.

Savvy Wellness formed a partnering relationship with RX CannaCare’s Founder and CEO, Twompson Prater, to create a line of quality CBD products.

Twompson’s extensive experience with cannabis and his development of a top quality CBD Skin Care line was the motivation for Savvy Wellness to seek him out for partnering.

Twompson’s original creation of RX CannaCare skincare products was an act of love for his sister, Alyxis. She was suffering from severe skin disorders and was using pharmaceutical products that were often hurting more than helping.

Prater had been prominent in the Cannabis industry in California for 15 years. One day he got a call from his sister, saying something like, “Hey big weed man, I really need help with my skin disorder! What can you do?”

Twompson was confident that he could create something that would help. That was the beginning of RX Canna Cream. The results for Alyxis were very promising. In her story, she said, “Not much time passed before I was seeing significant results from the Canna Cream. It was starting to make my skin look human again. It helped take away the intolerable itching feeling. It also put moisture back into my skin, especially where the steroid cream had done damage. Most of all, after a month or so, the itching and the visible appearance was completely gone.”

Because of Alyxis‘s eventual success and healing, she encouraged Twompson to develop more products and start a company. That is how RX Canna Care LLC was born.

One of the things that Twompson explored, when researching to develop his first Canna Cream, was the unnecessary ingredients he found in the products that were prescribed to his sister. He questioned why she kept breaking out and having unmanageable reactions. He then realized it was the ‘other ingredients’ that were there mainly as preservatives, to extend the products shelf life, that were the culprit. Those ingredients also blocked the effectiveness of the medicinal ingredients. The importance of using natural botanical ingredients with the CBD cannot be overstated.

After a running start in the CBD infused Skin Care industry, RX Canna Care is consistently on the innovative edge of this booming market. The number of people that suffer from skin disorders and other health-related issues is astronomical. CBD oil and Skin Care are proving to be a powerful natural alternative to chemically compounded treatments.

Dr. Mindell has been in the forefront of the natural health industry for many years. His profound understanding of natural healing and use of natural products is the foundation of his involvement in the Savvy Wellness CBD product line. His extensive research and subsequent book on CBD Oil has opened the way for this new business venture.

The partnering of Savvy Wellness with RX CannaCare is a significant contribution to the CBD products industry. With Twompson Prater at the helm of product development, Savvy Wellness will be able to offer top quality CBD infused, natural products that ‘Help and Heal’.

Dr. Mindell has weighed in and taken action in delivering the message of the vast benefits of CBD Oil. His book ‘Healing With Hemp CBD Oil’ is quickly becoming a favorite information source. The partnership of RX CannaCare and Savvy Wellness promises to deliver products that will soon be getting rave reviews!

Twompson Prater
Rx Canna Care LLC
email us here

Rx Canna Care And Savvy wellness

Source: EIN Presswire

"Undruggable" kRAS Cancer Gene Targeted by Drug Developer Tosk

Promising National Cancer Institute supported initiative to battle gene that drives many cancers featured in Roots Analysis interview with Tosk CEO Frenzel.

The kRAS gene drives some 90 percent of pancreatic, 45 percent of colorectal and 35 percent of lung cancers. Tosk received a $2 million grant from the NCI to develop drugs to counter the mutant gene.”

— Brian Frenzel, CEO, Tosk, Inc.

MOUNTAINVIEW, CALIFORNIA, USA, July 26, 2018 / — MOUNTAIN VIEW, CALIFORNIA, USA, July 26, 2018 / — Tosk Inc.’s promising drug discovery program targeting cancer causing kRAS gene mutations is featured in an interview of CEO Brian Frenzel by the highly respected pharmaceutical and biotech research and consulting group, Roots Analysis. Mr. Frenzel is well known in the biotech community for leading worldwide corporate planning for Syntex and subsequently co-founding four successful medical products companies.
The kRAS gene, which acts as a molecular on/off switch in cell signaling and proliferation, plays a critical role in many cancers. When it mutates, its signaling for cell growth increases, and the patient’s ability to control cell proliferation slows or stops, driving tumor growth. Many previous efforts to block kRAS gene activity have failed, and kRAS has become known as an “undruggable” target.
The kRAS gene drives about 90 percent of pancreatic cancers, 45 percent of colorectal cancers, and 35 percent of lung cancers. The gene also blocks the efficacy of EFGR-inhibiting drugs, such as Erbitux®, in about 40 percent of patients who might otherwise benefit from this therapy for colon, head and neck, and other cancers. Given the importance of the kRAS cancer gene, the U. S. National Cancer Institute (NCI) considers it a very high priority. The NCI collaborates with a number of research organizations in its efforts to solve the problem, including Tosk, which recently was awarded a $2 million grant from NCI.
“Tosk’s fruit fly-based drug screening technology offers an innovative new proprietary platform to identify drugs for difficult targets like kRAS,” Frenzel says. “We use a whole animal model, a genetically modified fruit fly, instead of the traditional approaches to drug screening. This helps us find drug candidates that work for difficult-to-modulate targets.” He adds that Tosk’s kRAS program is in the lead selection and optimization stage, with an application for an IND with the U.S. FDA to enter human clinical studies planned within 18 to 24 months.
Frenzel also told Roots Analysis that “in addition to the kRAS program, we are using a different fruit fly technology platform to identify drugs for other biological targets. Three drugs have emerged from this program, including one which has been in human trials for a year and another in late stage preclinical testing.”
Sizing the potential market for kRAS-related cancers therapies, Frenzel told Roots Analysis that “targeting the unserved 40 percent of patients who cannot use EGFR-inhibiting drugs plus potential monotherapy treatments for kRAS positive cancers yields an overall sales potential well into the billions of dollars.” As to the cost of drugs Tosk is developing, he emphasizes that “the cost of our therapeutics should be closer to that of typical small molecule drugs, making them affordable by most patients around the world. Tosk’s goal is to discover and develop very high value products that have the potential to reduce the overall cost of therapy while improving outcomes for cancer patients worldwide.”

Brian Frenzel
Tosk, Inc.
415 308-2820
email us here

Source: EIN Presswire

10 Skills You Need to Become a Successful Lab Manager

Lab managers working

Lab managers working

Formaspace laboratory phenolic tops

Formaspace laboratory phenolic tops

Are you a current lab manager or looking to become one? Read some of our tips on how to be successful in your career!

In larger organizations, the lab manager may have to interface with dedicated purchasing staff members”

— Formaspace

AUSTIN, TEXAS, UNITED STATES, July 26, 2018 / — As a provider of unique furniture solutions to laboratory facilities at major Fortune 500 companies for over 35 years, Formaspace has developed unique insights into the best practices used in today’s modern lab facilities. One key observation is the increasingly important (and diverse) role of laboratory managers.

Over the past 35 years that Formaspace has been working directly with Lab Managers, we’ve seen a lot of changes in the industry. Indeed, today’s lab managers wear multiple hats that require them to develop a broad set of effective management skills — ranging from chief problem solver to team facilitator.

If you are contemplating a career move into laboratory management or know someone that is, we’ve compiled a list of the top 10 effective management skills that every laboratory manager should master.

Let’s get started:

1. Laboratory Managers Need to Be Good Business and Project Managers

Overview: Don’t get us wrong. We’re not saying scientific research has to be all business (some of the best discoveries have been made in unorthodox ways). Instead, we’re saying that the role of laboratory management is to provide services to the investigators in a reliable businesslike manner, in order to provide seamless support for scientific research (or related services functions, such as in the case of IT labs).

Scope of Activities: Establish a vision and mission with both detailed short-term plans as well as long-term plans (5+ years out) that track progress on specific project goals, time management, and budgetary issues, such as income sources, spending, salaries.

Recommendations: Lab Managers overseeing large laboratory settings (in universities, government or healthcare / pharma) might benefit from business classes or an MBA in order to manage complex budgets and other requirements. Certification from PMI as a Project Management Professional (PMP) could also be helpful. Countless books, seminars, and online classes teach business management skills. If you are new to all this, then The One Minute Manager and Putting First Things First are two resources to look into.

2. Laboratory Management Typically Oversees Acquisition of Capital Equipment, Purchasing of Supplies and Services, and Inventory Control

Overview: In a small laboratory environment, much of this work will fall directly on the lab manager, who may be directly responsible for allocating budgetary funds (from a research grant for example). In larger organizations, the lab manager may have to interface with dedicated purchasing staff members. In either case, it’s important to adhere to rigorous government* policies that regulate service contracts as well as asset acquisition, use, and disposition activities.

(*Government contracts may require sourcing from vendors, like Formaspace, that are listed on GSA purchasing schedules.)

Scope of Activities: Set spending priorities during each budgetary cycle; identify requirements for capital equipment; investigate vendor options; ensure timely ordering procedures for consumable supplies (including bidding out if required); establish service contracts (such as for disposing of hazardous wastes); negotiate with the company or institution hosting the lab over assigned overhead costs to be borne by your budget; set up inventory tracking and control system as well as establish procedures to protect valuable or potentially dangerous assets from misuse or theft.

Recommendations: In addition to the recommendations for business and project management, new laboratory managers might look into taking classes in purchasing management. If you are working with the government or military, look for online seminars and guides (from the GAO, GSA, etc.). Establishing friendly contacts with the purchasing department of your company or institution early on is also a good idea (rather than waiting until there is a confrontational issue at hand). Ideally, you will be able to find a mentor who can help you understand the ins and outs of rules and procedures already in use at your institution or company.

3. Laboratory Managers Need to Develop Effective Management Skills in Public Relations and Internal Communications

Overview: Do you wonder why some laboratories always seem to be promoted in the news, or they have widespread support throughout the entire organization? Conversely, have you witnessed reports of laboratory errors or accidents that made the news and put the lab in the worst possible light? These are just two examples of how good (and bad) public relations and internal communications programs can affect your laboratory workplace.

Scope of Activities: Public Relations generally refers to a wide range of communication programs directed outside the organization (from community relations, to press coverage, to trade fairs), while internal communications programs are directed at internal audiences (to educate and promote positive awareness of your activities). Depending on the size of your organization, you may need to liaise with existing communications teams (or external agencies), or you may need to develop these resources yourself.

Recommendations: Generally speaking, having a robust external and internal communications program (assuming your work is not classified or a trade secret) will help win over support for activities taking place in your lab (which can be very useful at budget allocation negotiations). Working with your existing communications team (if any), you should consider hosting press events, public tours (if appropriate), provide useful press releases and social media postings to gain local (if not national) coverage. Consider providing media training to lab researchers (such as lead investigators) to improve their ability to communicate in language that targeted audiences can understand — using video recordings for feedback sessions can be very useful. Practice in advance how you would respond to a crisis (such as an accident or another adverse incident) by conducting realistic dry runs on how to communication with the press during that time. Make sure you know the private cell numbers of key administration staff who will need to be looped in at short notice.

4. Laboratory Management is Often in Charge of Education and Staff Development Programs for the Lab Team

Overview: Face-to-face meetings at scientific conferences, scientific journal subscriptions, and training classes are a few examples of education and staff development programs that will help lab team members grow in their field while improving morale at the same time.

Scope of Activities: Participation in most education and development programs (such as conferences and training classes) should be planned far in advance. Managers will need to identify and prioritize which activities and purchases will provide the most benefit for the lab — as well as make judicious choices for who will participate. Associated costs — ranging from time away from the lab to subscriptions, tuition, admission and travel expenses — will need to be budgeted for in advance.

Recommendations: Joining the relevant scientific or trade associations that govern your lab’s area of interest is a good place to start. Don’t overlook participation in standards committees or governing boards (if relevant) if you are looking for ways for your team members to network or raise your organization’s profile. Identifying mentors who can provide guidance to lab team members is another good approach. If travel expenses are an issue, but you have good facilities for hosting guests at your company or institution, consider creating your own event to bring relevant experts to your facility (this is an ideal initiative for lab interns to organize and run).

5. Successful Laboratory Managers Need to Learn How to Write and Administer Grants as Well as Protect Intellectual Property (IP)

Overview: As funding for major government-sponsored scientific grant programs faces further budgetary cutbacks, competition for limited grant monies has never been tighter. At the same time, there is increasing emphasis on the value of licensing Intellectual Property (IP) derived from important scientific discoveries.

Scope of Activities: As a laboratory manager, you may need to oversee grant writing activities; for many laboratories, the future of the lab itself may be on the line if funding sources cannot be identified. In cases where grants are awarded, the lab manager may also have some level of responsibility for administering the grant, including certifying that research activities are in compliance with the applicable statutory governance requirements before grant monies are issued. Protecting Intellectual Property (IP) is another responsibility that may require the lab manager’s oversight. Tasks here can range from making sure that the lead investigator’s scientific notebooks are secured and documented properly as well as interfacing with IP attorneys or technology transfers teams (now common at many research universities) who may seek to license valuable scientific discoveries.

Recommendations: Many Lab Managers will turn to grant specialist to write grant applications as well as manage grant funding, which may require adherence to proper accounting procedures and issuance of timely reports. Successful grant writing is a skill that can be learned with time; serving on a grant selection committee (many positions are open to the public) is an ideal way to learn about the grant evaluation and award process from an insider’s perspective. Reach out to your institution’s Intellectual Property team to learn the best practices for protecting scientific discoveries and maximizing licensing opportunities, if applicable.

6. Laboratory Management Typically Interfaces Directly with Infrastructure and Facility Management Teams

Read more …

Brooke Turner
email us here

Source: EIN Presswire

Specialty Enzymes Market – World Specialty Enzymes Industry 2018- 2023

Specialty Enzymes Market

Specialty Enzymes Market By Source, By Type, By Application, and By Region – Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Recent past has witnessed a tremendous growth of Specialty Enzymes due to their augmented use in pharma and biotech industries.”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, July 26, 2018 / — Proteins play a vital role in the human body and responsible for many changes in different tissues and organs. Enzymes are a kind of proteins that are helpful in many processes of the living organisms. Metabolism to respiration to waste discard to tissue management, enzymes play a vital role in the body. Lack or reduced enzyme capability may result in some severe ailments like heart diseases, infections, pain at different places, immunity degradation, digestion problems, and even cancer in some cases. These enzymes mostly fight with the deeper roots of any problem providing the complete cure in many critical illnesses. Whereas, Specialty enzymes are mostly living creatures secreted natural proteins used in the pharmaceutical and biotechnology industries to boost the chemical transformations.

Specialty enzymes are by far called as biocatalysts that can help in the development of several drugs by transforming the chemical compounds in the pharma industry. These kinds of enzymes are widely used in the DNA management, genetic engineering and other fields of molecular biology. The specialty enzymes used in several drugs are helpful in treating many diseases like cancer and HIV.

Request for sample:

The recent past has witnessed a tremendous growth of specialty enzymes due to their augmented use in pharma and biotech industries. Some of the growth factors driving their global market are demand for enzyme replacement therapies, use of biocatalysts in chemical components, increasing significance of systemic enzymes, usage of pharmaceuticals, more digestion related ailments, advent of many new companies in the market, advancements in enzyme production, surge of diagnostic enzymes, new innovations with the rise of technology, and so on.

On the contrary, the requirement for trained professionals, safety-related concerns for the storage, the lack of awareness among people, temperature constraints, availability of low price alternatives, expensive technology, and many other factors tend to inhibit the global specialty enzymes market extension.

To know more get our full report at

The full report provides all the information needed for the global specialty enzymes market along with the segregation of markets on the basis of type, application, source and geographical regions.

On the basis of type, the market is separated into
• Carbohydrase
• Protease
• Polymerase and Nuclease
• Lipase

The polymerase and nuclease segment is anticipated to have the greater market revenue and expected to grow similarly in the forecast period.

On the basis of application, the market is separated into
• Pharmaceuticals
• Diagnostics
• Research & biotechnology
• Bio-catalyst

The pharmaceuticals market with the rising chronic diseases and elderly population occupies the leading position in market share and expected to continue the same trend in years ahead.

On the basis of source, the market is separated into
• Animals
• Microorganisms
• Plants

As per the market research analysis, the animal-derived enzymes are expected to at an annual growth rate close to 10.5% in the report mentioned forecast period.

On the basis of regional distribution, the market is separated into
• Europe
• North America
• Middle East and Africa
• Latin America
• Asia Pacific

North America holds the principal market share for global specialty enzymes closely followed by Asia Pacific markets and predicted to hold more than 46% of market share by 2025. Asia Pacific is estimated to grow at a CAGR of around 12% during the prescribed time frame. US contributes a commanding market share to the North America region.

The competitive landscape is also portrayed in the full report and some of the market leaders in the industry include
• Genzyme Corporation
• Amano Enzyme, Inc.
• Advanced Enzyme Technology Ltd.
• The Soufflet group
• Sanofi S.A
• Affymetrix Inc.
• National Enzyme Company
• Life Technologies
• Codexis Inc.
• F Hoffman-La Roche Ltd and others

Recent trends in the market include technology licensing agreement between GSK and Codexis, distribution deal between Novozymes and China National Pharmaceutical Foreign Trade, acquisition of Enzyme solutions by Connell Brothers, introduction of GingisKhan by Genovis AB, and others reveal a promising growth for the global specialty enzymes market in the future irrespective of several odds restraining the expansion.

Download Free sample @ Feed Enzymes Market, Baking Enzymes Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206

Sai Kutumbarao
Market Data Forecast
email us here

Source: EIN Presswire

Lasers Are Powerful Healing Tools When Used With Expertise

Visible laser light illuminating blood vessels in hand

Dr. Nelson Marquina, Ph.D, Founder and Chief Technology Officer, Laser Biotech International

World Class Laser Practitioner Certification Program coming to Philadelphia Sept. 22nd-23rd

RICHMOND, VA, USA, July 25, 2018 / — Philadelphia's Crowne Plaza and the Pennsylvania Chiropractic Association will host Dr. Nelson Marquina's Laser Practitioner Certification Program the weekend of September 22nd.

This one of a kind certification program delivers the scientific and hands-on training that will ensure high proficiency in the effective use of therapeutic lasers. Covering topics such as how to accurately tailor wattage and nanometers for specific results and using the laser as a tool in the diagnostic process, you and your staff will learn how to create effective treatment plans with specific techniques for reducing inflammation and resolving pain.

The course is offered to chiropractors and other physical medicine practitioners, as well as their staff.

Register with the Pennsylvania Chiropractic Association

Call: 717-232-5762

The course price covers materials and you will receive a certificate upon successful completion as well as 12 CEU's in PA, MD, OH and NJ.
PCA Members: $199
Non-Members: $249

Staff members must attend with a licensed physician.

Previous course attendees say after completing the course that it was “One of the best practical classes I have ever taken.” Filled with “Practical information I can implement on Monday morning!” and “Practical applications, lots of examples, clearly the instructor is an expert on the subject.”

You may notice one word repeated throughout those comments—practical! This world-class information and hands-on experience will be immediately transferable to healing patient pain in real time, safely and effectively. Soon you and your practice will be standing out in comparison to others in your field of expertise.

Speaking of expertise, Dr. Nelson Marquina—your instructor—is an internationally-renowned expert in the field of laser therapy. This is not a statement made without merit! Dr. Marquina is so invested in the positive healing abilities of lasers that he developed the technical specs for the manufacturers of the Lumix lasers that we offer physicians. He also developed the biophotonic and bioelectromagnetic systems and treatment protocols for the healing applications of those lasers, which were the first lasers of their kind to receive FDA clearance in 2004.

Dare we say, Dr. Nelson Marquina “knows his stuff” and is very passionate about helping more physicians have the means to effectively treat patient pain. So, don’t miss this opportunity to advance your abilities in the field of laser therapy.

Elizabeth Southard
Laser Biotech International
email us here

Laser Therapy Offers Tremendous Relief From TMD

Source: EIN Presswire

BDA International Release: Co-Diagnostics Inc.: CE markers and anticipated Future Growth

Co-Diagnostics, Inc. (“CODX”) is a molecular diagnostics company that has developed a unique, patented and patent-pending diagnostic testing technology. A Utah corporation headquartered in Salt Lake City, Utah, its primary business is to commercialize its technology through sales, development and licensing. The innovative technology is embodied in 5 patents granted and pending and certain trade secrets, which make DNA testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. In addition to infectious disease testing, it also has broad applications for liquid biopsy, next-gen sequencing, and SNP detection.

Today the Company announced today that its Logix Smart™ MTB Test technical file has been approved for registration with the European Community, and that the CE marked in vitro diagnostic (“IVD”) is expected to be available for purchase early in August in markets that accept a CE mark as valid regulatory approval.

The Logix Smart MTB Test detects DNA of mycobacteria tuberculosis (MTB) complex members and functions via real-time polymerase chain reaction (PCR) to detect and amplify the regions of the MTB genome.

The key component to battling tuberculosis is an early, accurate, and affordable diagnosis. The Company expects that this will help them to better meet the global demand for detection of a disease that causes over 1.5 million deaths per year. Roughly 95% of these deaths occur in low and middle-income countries, which includes those in Eastern Europe in addition to many across Central America and the Caribbean basin. In the case of the latter, the Departments or Ministries of Health recognize clearance by the European Community as valid regulatory approval to allow sale of CE marked products throughout their jurisdictions.

With the number of infections upwards of 10.5 million per year, and 99.9% of those occurring outside the United States, the Company believes that a CE marking is the most appropriate and effective route to address this growing market in need of a competitively-priced diagnostics solution, which they also anticipate will have a positive impact on their financial growth in the future.

Access Coverage of Co-Diagnostics at:

Forward-Looking Statements:

This press release contains forward-looking statements. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The Company and The Wall Street Club undertake no obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws. The Wall Street Club is neither a registered broker-dealer nor a registered investment advisor and has been paid to feature this company. For more information please read our disclosure statement at:

European Office
BDA International Investor Relations
email us here

Source: EIN Presswire